ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision makingHans‐Joachim Schmoll, Andrés Cervantes, Eric Van Cutsem et al.|Annals of Oncology|2012Cited by 1.5k
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort studyMarlies Kempers, Marjolijn J. L. Ligtenberg, Bernadette P. M. van Nesselrooij et al.|The Lancet Oncology|2010Cited by 293
DUTCH COLORECTAL CANCER GROUP. PREOPERATIVE RADIOTHERAPY COMBINED WITH TOTAL MESORECTAL EXCISION FOR RESECTABLE RECTAL CANCEREllen Kapiteijn, Cornelis JH van de Velde, Corrie A.M. Marijnen et al.|Unknown|2001Cited by 229
Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancerT. H. van Dijk, Klaas Havenga, K Tamás et al.|Annals of Oncology|2013Cited by 147
Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical studyIrıs D. Nagtegaal, J. Han van Krieken, Corrie A.M. Marijnen et al.|BMC Cancer|2001Cited by 142